why choose us

First received: February 03, 2023

Clinical Trial: A Phase 1, First-in-human Study of VX-668

Study Status: Completed

Recruit Status: RECRUITING

Condition: Alpha-1 Antitrypsin Deficiency

Study Type: INTERVENTIONAL


Official Title: A Phase 1, First-in-human Study of Safety, Tolerability, and Pharmacokinetics of VX-668

Brief Summary: The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics (PK) of VX-668 at various doses.

Read more